title: The effect of diosmin hesperidin on intestinal ischaemia--reperfusion injury.
abstract: OBJECTIVE
  The effect of Diosmin Hesperidin on intestinal ischaemia reperfusion injury was evaluated in an experimental model in rats.
  
  
  METHODS
  Forty Spraque-Dawley rats were divided into 4 groups of (n = 10) (sham, sham + Diosmin Hesperidin, Reperfusion, Reperfusion + Diosmin Hesperidin). Diosmin Hesperidin oral gavage was administrated at a dose of 50 mg/kg to rats 14 and 2 hours before the operation and 30 minutes of ischaemia and 30 minutes of reperfusion was performed in the groups when appropriate. Ileum samples were resected for histopathological evaluation and tissue malondialdehyde (MDA) and myeloperoxidase (MPA) level determination.
  
  
  RESULTS
  Mean mucosal injury score of IR group (4,50+/-0,23) was significantly higher than the other groups (p < 0.05). Although mean mucosal injury score of IR + DH group was higher than sham and sham + DH groups, difference was not statistically significant (p > 0.05). Tissue MDA and MPO activities of IR group were 45,55+/-2.61 nmol/g/wet tissue and 1.68+/-0.25 U/g/wet tissue respectively and were significantly higher than the other groups (p < 0.008). Although tissue MDA and MPO activities of IR + DH group was higher than sham and sham + DH groups, differences were not statistically significant (p > 0.008).
  
  
  CONCLUSIONS
  Diosmin Hesperidin seems to be effective in the prevention of intestinal reperfusion injury.
authors.affiliation: Department of General Surgery, Medical School, Abant Izzet Baysal University, Duzce, Turkey.
authors.forename: M
authors.initials: M
authors.lastname: Pehlivan
authors.forename: S M
authors.initials: SM
authors.lastname: Hazinedaroglu
authors.forename: H A
authors.initials: HA
authors.lastname: Kayaoglu
authors.forename: A B
authors.initials: AB
authors.lastname: Erkek
authors.forename: T
authors.initials: T
authors.lastname: Keklik
authors.forename: O
authors.initials: O
authors.lastname: Canbolat
authors.forename: S
authors.initials: S
authors.lastname: Kocak
mesh_terms: D000818:Animals; D004145:Diosmin / Q000627:therapeutic use*; D005419:Flavonoids / Q000627:therapeutic use*; D006569:Hesperidin / Q000627:therapeutic use*; D007410:Intestinal Diseases / Q000517:prevention & control*; D007422:Intestines / Q000098:blood supply; D008297:Male; D023421:Models, Animal; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000517:prevention & control*
chemical_list: D005419:Flavonoids; D004145:Diosmin; D006569:Hesperidin